CURE’s breast cancer page is an extensive resource of cancer information featuring the latest breast cancer news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and medical data on breast cancer.
July 7th 2025
It took years to understand why my mastectomy site looked different. Knowing I healed correctly for my procedure helped me accept my new normal.
FDA Approves Lynparza for BRCA-Positive Breast Cancer
January 12th 2018Lynparza (olaparib) was granted approval by the Food and Drug Administration (FDA) for the treatment of patients with BRCA-positive, HER2-negative metastatic breast cancer who have previously received chemotherapy. Also, patients who have HR-positive disease should have prior endocrine therapy or they would not be considered appropriate for such treatment.
Kisqali Granted Breakthrough Therapy Designation for Breast Cancer Subset
January 4th 2018Kisqali (ribociclib) was granted a breakthrough therapy designation by the Food and Drug Administration (FDA) to be used in combination with tamoxifen or an aromatase inhibitor (AI) in the frontline treatment of pre- or perimenopausal women who have hormone receptor-positive HER2-negative advanced or metastatic breast cancer.
Facing the Responsibilities of the New Year
December 29th 2017The new year impacts breast cancer survivors in a vastly different ways than it does most people. Our resolutions, especially health-related resolutions, can be detrimental to our health if we don't keep them. This survivor shares her own chagrin at failing to keep some promises.